1. Miljkovic MD, Jones BL, Miller K. From the Euthanasia Society to physician orders for life-sustaining treatment: end-of-life care in the United States. Cancer J. 2013; 19:438–43.
2. Tanaka M, Kodama S, Lee I, Huxtable R, Chung Y. Forgoing life-sustaining treatment: a comparative analysis of regulations in Japan, Korea, Taiwan, and England. BMC Med Ethics. 2020; 21:99.
Article
3. Choi K. Legal and ethical issues regarding end-of-life care in Korea. J Asian Sociol. 2016; 45:151–64.
4. Kim M. The problems and the improvement plan of the Hospice/Palliative Care and Dying Patient’s Decisions on Life-Sustaining Treatment Act. Korean J Hosp Palliat Care. 2018; 21:1–8.
Article
6. Jin S, Kim J, Lee JY, Ko TY, Oh GM. End-of-life care practice in dying patients after enforcement of Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life: a single center experience. Korean J Hosp Palliat Care. 2020; 23:93–102.
7. Kim JS, Yoo SH, Choi W, Kim Y, Hong J, Kim MS, et al. Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients. Cancer Res Treat. 2020; 52:917–24.
Article
8. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43:1130–9.
Article
10. An HJ, Jeon HJ, Chun SH, Jung HA, Ahn HK, Lee KH, et al. Feasibility study of physician orders for life-sustaining treatment for patients with terminal cancer. Cancer Res Treat. 2019; 51:1632–8.
Article
11. Park HY, Kim YA, Sim JA, Lee J, Ryu H, Lee JL, et al. Attitudes of the general Public, cancer patients, family caregivers, and physicians toward advance care planning: a nationwide survey before the enforcement of the Life-Sustaining Treatment Decision-Making Act. J Pain Symptom Manage. 2019; 57:774–82.
Article
12. Kim DY, Lee KE, Nam EM, Lee HR, Lee KW, Kim JH, et al. Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med. 2007; 10:1153–8.
Article
13. Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience. Support Care Cancer. 2006; 14:103–8.
Article
14. Baek SK, Chang HJ, Byun JM, Han JJ, Heo DS. The association between end-of-life care and the time interval between provision of a do-not-resuscitate consent and death in cancer patients in Korea. Cancer Res Treat. 2017; 49:502–8.
Article
15. Becker G, Sarhatlic R, Olschewski M, Xander C, Momm F, Blum HE. End-of-life care in hospital: current practice and potentials for improvement. J Pain Symptom Manage. 2007; 33:711–9.
Article
16. Celso BG, Meenrajan S. The triad that matters: palliative medicine, code status, and health care costs. Am J Hosp Palliat Care. 2010; 27:398–401.
Article
17. Choi Y, Keam B, Kim TM, Lee SH, Kim DW, Heo DS. Cancer treatment near the end-of-life becomes more aggressive: changes in trend during 10 years at a single institute. Cancer Res Treat. 2015; 47:555–63.
Article
18. Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, et al. Chemotherapy use and associated factors among cancer patients near the end of life. Oncology. 2007; 72:164–71.
Article
19. Keam B, Oh DY, Lee SH, Kim DW, Kim MR, Im SA, et al. Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol. 2008; 38:381–6.
Article
20. The 2019 annual report on the life-sustaining treatment decision system. Seoul: Korea National Institute for Bioethics Policy;2019.